Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
70,592
-
Shares change
-
+12,817
-
Total reported value, excl. options
-
$10,465
-
Value change
-
-$28,546
-
Number of buys
-
2
-
Number of sells
-
-4
-
Price
-
$1
Significant Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) as of Q3 2024
9 filings reported holding TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share as of Q3 2024.
Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70,592 shares
.
Largest 10 shareholders include WEDBUSH SECURITIES INC (40,540 shares), LPL Financial LLC (30,049 shares), Allworth Financial LP (1 shares), Planning Capital Management Corp (1 shares), CENTRAL TRUST Co (1 shares), Global Retirement Partners, LLC (0 shares), ACADIAN ASSET MANAGEMENT LLC (0 shares), Activest Wealth Management (0 shares), JPMORGAN CHASE & CO (0 shares), and MILLENNIUM MANAGEMENT LLC (361,445 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.